Chargement en cours...
Severe pneumonitis refractory to steroids following anti-PD-1 immunotherapy
Anti-programmed death 1 (PD-1) immune checkpoint inhibitors enhance the antitumour activity of the immune system and have produced durable tumour responses in several solid tumours including non-small cell lung cancer (NSCLC). However, PD-1 inhibitors can lead to immune-related adverse events, inclu...
Enregistré dans:
| Publié dans: | BMJ Case Rep |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6194409/ https://ncbi.nlm.nih.gov/pubmed/30301729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-225937 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|